SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001698530-22-000026
Filing Date
2022-05-13
Accepted
2022-05-13 16:12:54
Documents
17
Period of Report
2022-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xcur-20220509.htm   iXBRL 8-K 47244
2 EX-10.1 ex101-exicure2022pipesecur.htm EX-10.1 206991
3 EX-10.2 ex102-exicure2022piperegis.htm EX-10.2 202573
4 EX-99.1 ex991_pressreleasedated051.htm EX-99.1 15477
8 exicureimage1a10a.gif GRAPHIC 2794
9 image_1a.jpg GRAPHIC 69
  Complete submission text file 0001698530-22-000026.txt   703509

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20220509.xsd EX-101.SCH 1905
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20220509_lab.xml EX-101.LAB 24831
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20220509_pre.xml EX-101.PRE 13045
11 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20220509_htm.xml XML 10984
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39011 | Film No.: 22922847
SIC: 2834 Pharmaceutical Preparations